June 2, 2014
CAMBRIDGE, Mass. –– Scientists at Nuclea Biotechnologies, Inc. and Thermo Fisher Scientific are pooling their expertise to develop novel multiplexed research methods for high-throughput quantification of native insulin and its therapeutic analogs. Monitoring the levels of these markers may be useful in predicting the response to therapy for Type 2 diabetes. Nuclea has extensive experience [...]
Inframatic 9500 approved in Austria
June 2, 2014
Stockholm, Sweden -- The IM 9500 NIR Grain Analyzer has been officially approved by the BEV(Bundesamt für Eich- und Vermessungswesen), the national metrology institute providing scientific and technical services in Austria. BEV has evaluated the IM 9500 and concluded that it meets the requirements for official determination of moisture. With this approval, number 3904/2013, the [...]
Avantor Performance Materials Names William E. Redmond, Jr. to Board of Directors
June 2, 2014
CENTER VALLEY, PA -- Avantor™ Performance Materials, a global manufacturer and supplier of high-performance chemistries, announces the appointment of William E. Redmond, Jr. to its Board of Directors. Mr. Redmond brings extensive experience to the Avantor Board of Directors. In his career, Mr. Redmond has served as a chief executive officer or director of more [...]
DefiniGEN announces closing of £2.3 million ($3.8 million) Series A Fundraising
June 2, 2014
DefiniGEN Ltd, a leading provider of stem cell life science products and services, today announced the final closing of its Series A funding round. The latest £1 million ($1.6 million) placement for ordinary shares brings to a close a cumulative total for the round of £2.28 million ($3.83 million), which will support the international expansion [...]
Roche acquires Genia Technologies to strengthen next generation sequencing pipeline
June 2, 2014
Basel -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today the acquisition of Genia Technologies, Inc. (Genia), a privately held company, based in Mountain View, California, USA. Genia is developing a single-molecule, semiconductor based, DNA sequencing platform using nanopore technology. Under the terms of the agreement, Roche will pay Genia’s shareholders USD 125 million in [...]
OGT to sell Cytocell products direct in North America
June 2, 2014
Oxford Gene Technology (OGT), The Molecular Genetics Company, has announced that following its acquisition of Cytocell in March, it will directly sell Cytocell products to the North American market from the 1st June 2014. New and existing Cytocell customers in North America will now benefit from OGT’s expert and experienced sales and support infrastructure, which [...]
Contract Research Organizations To Adopt Ion Torrent Next-Generation Sequencing Platform
June 2, 2014
CARLSBAD, Calif.-- Two Contract Research Organizations (CROs) with leading expertise in molecular testing have decided to utilize the new Oncomine Cancer Research panel, which runs on Life Technologies Ion Torrent sequencing instruments, for clinical trial analyses and design. This comprehensive multi-biomarker assay allows concurrent analyses of DNA and RNA in one workflow, allowing researchers to [...]
June 2, 2014
Singapore -– The National University of Singapore (NUS) Environmental Research Institute (NERI) and Shimadzu (Asia Pacific) Pte Ltd, a global leader in the manufacturing of analytical instruments, testing instruments, precision instruments, measuring instruments and medical equipment, are collaborating to conduct research on environmental contaminants. To mark this partnership, Mr Yasuo Miura, Director, Shimadzu Corporation, and [...]
ENZO BIOCHEM ANNOUNCES APPOINTMENT OF JAMES M. O’BRIEN AS SENIOR VP, FINANCE
May 30, 2014
NEW YORK, NY -– Enzo Biochem, Inc. (NYSE:ENZ), a vertically integrated biosciences and clinical laboratory company, announced today the appointment of James M. O’Brien as Senior Vice President, Finance. “Jim has an impressive professional background and brings over 15 years of experience leading and managing all financial functions for a number of diverse global organizations. [...]
May 30, 2014
CHICAGO -– Appistry, Inc., a leading provider of tools, software, and services that bring the power of genomics to next-generation medicine, announced today the launch of Appistry CloudDx™, a cloud-based service for ordering genomics tests. By collecting established laboratory-developed tests (LDTs) in a single, easy-to-access environment and streamlining the processes associated with delivering clinically relevant [...]
